Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.77
-0.0700-1.20%
Post-market: 5.67-0.1000-1.73%19:59 EST
Volume:936.49K
Turnover:5.41M
Market Cap:312.64M
PE:-1.60
High:6.06
Open:5.81
Low:5.61
Close:5.84
Loading ...

Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates

Zacks
·
07 Nov 2024

Emergent BioSolutions Q3 2024 Adj. EPS $1.37 Beats $0.14 Estimate, Sales $293.800M Miss $297.500M Estimate

Benzinga
·
07 Nov 2024

BRIEF-Emergent Biosolutions supports new clinical trial evaluating the safety and efficacy of Brincidofovir in treating Mpox virus across Africa

Reuters
·
07 Nov 2024

Emergent Biosolutions: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

Emergent BioSolutions Inc - Study to Evaluate Safety and Efficacy of Tembexa for Mpox

THOMSON REUTERS
·
07 Nov 2024

Emergent BioSolutions Inc - Mosa Trial to Begin in Drc and Neighboring Countries

THOMSON REUTERS
·
07 Nov 2024

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

THOMSON REUTERS
·
07 Nov 2024

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

GlobeNewswire
·
07 Nov 2024

Emergent BioSolutions Inc: Qtrly Adj EPS $1.37

THOMSON REUTERS
·
07 Nov 2024

Emergent BioSolutions Inc Outlook FY Total REV $1,065 Mln - $1,125 Mln

THOMSON REUTERS
·
07 Nov 2024

Emergent BioSolutions reports Q3 adjusted EPS $1.37 vs. ($1.09) last year

TIPRANKS
·
07 Nov 2024

BRIEF-Emergent BioSolutions Q3 Revenue USD 293.8 Million

Reuters
·
07 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
06 Nov 2024

BRIEF-Emergent Biosolutions Appoints Dr. Simon Lowry As Chief Medical Officer And Head Of Research And Development

Reuters
·
04 Nov 2024

Emergent BioSolutions Appoints DR. Simon Lowry as Chief Medical Officer and Head of Research and Development

THOMSON REUTERS
·
04 Nov 2024

Press Release: Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development

Dow Jones
·
04 Nov 2024